research and development news
Afrezza could breathe new life into inhaled insulin market
August 15, 2011Research and Development, Sales and Marketing diabetes, inhaled insulin, insulin, research and development news
New trials for MannKind’s investigational inhaled insulin drug Afrezza have been given the go-ahead by the FDA, potentially breathing new …
Study shows new genetic risk factors for MS
August 15, 2011Research and Development genes, multiple sclerosis, research and development news
New genetic links to the immune system have been identified as a possible trigger for multiple sclerosis. The exact causes …
Contract research news in brief
July 27, 2011Research and Development research and development news
PPD plays down sell-off rumours, Icon sees a steep profit decline, plus updates from Beaufort, PharmaNet, ClinStar and Biofocus/IMD. PPD …
BMS makes $325m biotech acquisition
July 25, 2011Research and Development, Sales and Marketing BMS, biotech, research and development news
Bristol-Myers Squibb is to plug gaps in its pipeline by buying private biotech company Amira Pharmaceuticals for $325 million in …
Lilly presents data on failed Alzheimer’s candidate
July 21, 2011Research and Development Alzheimer's disease, lilly, research and development news, semagacestat
Lilly has presented a review of data from semagacestat, the Alzheimer’s drug it dropped last year after disappointing results. Phase …
Future of AZ-BMS diabetes drug in doubt
July 20, 2011Research and Development, Sales and Marketing AstraZeneca, BMS, dapagliflozin, diabetes, research and development news
A US advisory committee has rejected an investigational compound for type II diabetes sufferers, throwing its future into doubt. Dapagliflozin, …
Contract research news in brief
July 20, 2011Research and Development research and development news
M&A abounds in the CRO sector with INC completing its purchase of Kendle, inVentiv snappig up Pharmanet and ICON buying …
France cleans up regulation – and restricts pharma role
July 14, 2011Research and Development, Sales and Marketing France, Mediator, Servier, pharmacovigilance, research and development news
France has unveiled sweeping changes to how it regulates prescription medicines following the scandal surrounding Servier’s Médiator. Health minister Xavier …
Sanofi eyes phase III move for sarilumab in rheumatoid arthritis
July 13, 2011Research and Development Regeneron, Sanofi, ankylosing spondylitis, research and development news, rheumatoid arthritis, sarilumab
Sanofi is poised to move sarilumab into phase III trials for rheumatoid arthritis after the monoclonal antibody showed positive results …
Pharma regulators consult on drug development initiatives
July 13, 2011Research and Development Companion Diagnostics, EMA, FDA, Pharmacogenomics, biomarkers, research and development news
Pharma regulators in the US and Europe have put out separate consultations on issues affecting how medicines are developed. The …
Amgen collaborates on cancer antibody research
July 13, 2011Research and Development Amgen, Cancer, TGF-beta monoclonal antibody, research and development news
Amgen has teamed up with German biotech Micromet to develop tumour-destroying antibodies in a two-year deal that could net Micromet …
Sanofi to research new types of antibiotics
July 6, 2011Research and Development Antibiotics, Rib-X Pharmaceuticals, Sanofi, research and development news
Sanofi has signed a research collaboration with Rib-X Pharmaceuticals to investigate new types of antibiotics. The French pharma company has …
Contract research news in brief
July 6, 2011Research and Development CIToxLAB, Jubilant, PupPharma, Quintiles, Toxikon, research and development news
Quintiles helps fund Alzheimer’s drug programme, Toxikon starts building a new facility, plus updates from Jubilant, CIToxLAB and PupPharma. Quintiles …
